METHODS FOR PRODUCTION OF ATRIAL PROGENITORS AND THEIR DIFFERENTIATION INTO SMOOTH MUSCLE CELLS AND CARDIOMYOCYTES

Transgenic trasnchromosomal rodents for making human antibodies

Knockout mice for a P450 gene cluster

Methods of using human tissue factor-producing knock-in mice

Non-human gene-disrupted animal with disrupted ADAM11 gene

Uses of Sperm Membrane Protein OBF

Method of expanding human hepatocytes in vivo

Animal Model Based on Targeted Apoptosis for the Study of Genetic Diseases Such as Parkinson's Disease

STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF

Human monoclonal antibodies against CD30

Transgenic non-human animals for pharmacological and toxicological studies

RNA interference mediating small RNA molecules

TREATMENT OF FIBROSES AND LIVER DISORDERS

ACE2 activation for treatment of heart, lung and kidney disease and hypertension

Inhibitors of Caspase I-Dependent Cytokines in the Treatment of Neurodegenerative Disorders

Adropin deficient mice and uses thereof

NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER

NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER

Transgenic mouse with a homozygous mutation in the CMAH gene

RNA interference mediating small RNA molecules

Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes

Transgenic Zebrafish Models for Neurodegenerative Diseases

METHOD OF SCREENING PTP ZETA ACTIVITY PROMOTER OR INHIBITOR

MEMORY AND LEARNING IMPAIRMENTS ASSOCIATED WITH DISRUPTION OF EPHRIN RECEPTOR A6 (EphA6) GENE

Micro-RNA family that modulates fibrosis and uses thereof

Novel Neurotrophic Factor Protein and Uses Thereof

ESTROGEN RECEPTOR-RELATED RECEPTOR GAMMA (ERR GAMMA) IN BONE AND CARTILAGE FORMATION AND METHODS AND COMPOSITIONS RELATING TO SAME

TWO STEP CLUSTER DELETION AND HUMANISATION

Glycine N-methyltransferase (GNMT) Animal model and use thereof

Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling

MOUSE MODEL FOR DEPRESSION, SCHIZOPHRENIA AND ALZHEIMER'S DISEASE

Apo-2DcR

COMPOSITIONS AND METHODS FOR MODULATING S-NITROSOGLUTHIONE REDUCTASE

Mouse models with enhanced essential tremor and preparation method thereof

Properdin Modulation of Alternative Pathway and Uses Thereof

SHIP-deficiency to increase megakaryocyte progenitor production

Knockin mouse with a disruption in a PXR gene expressing human PXR

Remedy for the treatment of cardio-vascular diseases or disorders

TRANSGENIC MICE EXPRESSING HUMAN FORMYL PEPTIDE RECEPTOR

Using cytosine deaminases to diminish retroelement transfer from pigs to humans

Regulator of ephrin-Eph receptor signaling and mouse having abnormal ephrin-Eph receptor signaling mechanisms

Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify same

Novel Neurological Function of mPKCI

Transgenic mice for assessing drug metabolism and toxicity

Use of Nestafin-1 in the Treatment for Diabetes

NOVEL GENE DISRUPTIONS, COMPOSITIONS AND THE METHODS RELATING THERETO

Method of Treating Pain by Using Opioids and CAMKIV Inhibitors

MOUSE IN WHICH GENOME IS MODIFIED

IL-21 RECEPTOR KNOCKOUT ANIMAL AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASES

Inhibitors of PDE4 and Methods of Use

METHODS FOR RELIEVING NEUROPATHIC PAIN BY MODULATING ALPHA 1G T-TYPE CALCIUM CHANNELS AND MICE LACKING ALPHA 1G T-TYPE CALCIUM CHANNELS

Methods for the treatment or prevention of hemorrhagic conditions

SELECTIVE INHIBITION OF HISTONE DEACETYLASES 1 AND 2 AS A TREATMENT FOR CARDIAC HYPERTROPHY

Methods for producing transgenic rodents having recombinant immunoglobulin loci

REGENERATION AND SURVIVAL OF CARDIAC PROGENITORS AND CARDIOMYOCYTES WITH A STRETCH ACTIVATED TRANSCRIPTION FACTOR

Lysyl oxidase-like 1 (LOXL1) and elastogenesis

TUMOR SUPPRESSOR DESIGNATED TS10Q23.3

Immunoglobulins comprising predominantly a Man3GlcNAc2 glycoform

Method for determining MIF content

METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS AND IMPAIRED LUNG FUNCTION AND TO ENHANCE LYMPHOCYTE PRODUCTION

Tat-005 and Methods of Assessing and Treating Cancer

Nonhuman model animal lacking the ability to control lymphocyte migration

Methods of using angiopoietin-like 4 protein to stimulate proliferation of pre-adipocytes

TARGETED GENE DISRUPTIONS IN THE IQGAP2 GENE

ANIMAL MODEL

METHOD AND COMPOSITIONS FOR MODULATING TH17 CELL DEVELOPMENT

Novel therapeutic and diagnostic products and methods

Methods for increasing the diversity of monoclonal antibodies produced against an antigen

Compositions and methods for increasing bone mineralization

METHODS AND COMPOSITIONS RELATING TO ZPA POLYPEPTIDES

26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor

Use of Tumor Necrosis Factor-Alpha P75 Receptor for the Reduction of Inflammation

Antibody producing non-human mammals

TRANSGENIC ANIMAL MODEL FOR MODELLING PATHOLOGICAL ANXIETY, A METHOD FOR IDENTIFYING COMPOUNDS FOR TREATMENT OF DISEASES OR DISORDERS CAUSED BY PATHOLOGICAL ANXIETY AND A METHOD FOR USING WFS1 PROTEIN AS A TARGET FOR IDENTIFYING EFFECTIVE COMPOUNDS AGAINST PATHOLOGICAL ANXIETY

TRANSGENIC NON-HUMAN ANIMAL

THERAPEUTIC AGENTS FOR ANGIOGENESIS-RELATED DISEASES COMPRISING CHONDROMODULIN-I AS ACTIVE INGREDIENT

Reduction of graft-versus-host disease by modulation of SHIP activity

INHIBITION OF GPR4

Modified animal lacking functional PYY gene, monoclonal antibodies that bind PYY isoforms and uses therefor

METHODS OF TREATING DISORDERS ASSOCIATED WITH FAT STORAGE

Transgenic chickens with an inactivated endogenous gene locus

IDENTIFICATION OF GROUP OF HYPERTENSION-SUSCEPTIBILITY GENES

MAVS IN THE PREVENTION AND TREATMENT OF VIRAL DISEASE

HISTONE DEACETYLASES, AND USES RELATED THERETO

Artery- and vein-specific proteins and uses therefor

Osteopontin Specific Antibodies and Methods of Use Thereof

CELLS EXPRESSING ALPHA-SYNUCLEIN AND USES THEREFOR

H-Chain-only antibodies

Models of thrombotic thrombocytopenic purpura and methods of use thereof

Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors

Animal model and use of 17beta-hydroxysteroid dehydrogenase type 7 in the diagnosis of anencephaly

Double-muscling in mammals

C-REACTIVE PROTEIN (CRP) KNOCKOUT MOUSE

Method for preventing and treating cardiovascular diseases with BRCA1

CRANIAL AND VERTEBRAL DEFECTS ASSOCIATED WITH LOSS-OF-FUNCTION OF NELL1

METHODS AND COMPOSITIONS FOR RNAI MEDIATED INHIBITION OF GENE EXPRESSION IN MAMMALS

Regulation of lipid droplet formation by modulation of FIT1 and FIT2 and uses thereof

METHODS AND REAGENTS FOR SCREENING NEW DRUGS AND FOR TREATING ION PUMP ASSOCIATED DISORDERS AND DISEASES

SCREENING METHOD WITH THE USE OF TBK1 KNOCKOUT MOUSE

Treatment of Pompe's Disease

MO-1, A Gene Associated With Morbid Obesity

Ungulates with genetically modified immune systems

GENES AND PATHWAYS INVOLVED IN BIPOLAR DISORDER

Animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

Animal having modification in MGAT2 gene

Antibody producing non-human mammals

Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

Expression of Class 2 mannosidase and Class III mannosidase in lower eukaryotic cells

Expression of Class 2 mannosidase and Class III mannosidase in lower eukaryotic cells

Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis

Transgenic non-human animals expressing a truncated activin type II receptor

Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency

PROTEIN FORMULATIONS COMPRISING S1-5

Cardiac hypertrophy

DRG11-Responsive (DRAGON) Gene Family

Application of actin-binding protein to disease associated with cell motility

KNOCKOUT ANIMAL EXHIBITING ANXIETY-LIKE BEHAVIOR

YEAST GENES THAT AFFECT VIRAL REPLICATION

Human CTLA-4 antibodies and their uses

Transgenic Frog Lines and Assays Employing Them

Use of VEGF and homologues to treat neuron disorders

Compositions and methods for treating lysosomal storage disease

Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists

Mouse model for eye disease

Prion-free transgenic ungulates

Prostate Epithelial Androgen Receptor Suppresses Prostate Growth and Tumor Invasion

Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells

Compositions and methods for treating kidney disease

METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE MEMORY BY BLOCKING INTRAHEPATIC ACTIVATED T CELL DELETION

MODEL FOR MUSCULAR DYSTROPHY AND CARDIOMYOPATHY

CHIMERIC NON-HUMAN ANIMAL

IMMUNODEFICIENT MICE TRANSGENIC FOR HLA CLASS I AND HLA CLASS II MOLECULES AND THEIR USES

RNA INTERFERENCE MEDIATING SMALL RNA MOLECULES

Human antibodies derived from immunized xenomice

Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Saspase knockout animal

Genetically modified heart valve xenografts

COMPLEMENT INHIBITORY AGENTS AS THERAPEUTICS IN POSTTRAUMATIC AND DEGENERATIVE ARTHRITIS

Antibodies to PRO352

MG53 compositions and methods of use

Methods of identifying candidate compounds of the human G protein-coupled receptor, GPR50, as modulators of body mass or adiposity

Gene disruptions, compositions and methods relating thereto

Kits for diagnosing a hypophosphatemic disorder

ISOLATION OF THE T-COMPLEX DISTORTERS AND APPLICATIONS THEREOF

GENERATION OF HEAVY-CHAIN ONLY ANTIBODIES IN TRANSGENIC ANIMALS

Methods and compositions for using zinc finger endonucleases to enhance homologous recombination

Nucleic acid sequences and homologous recombination vectors for distruption of a Fel D I gene

Use of Caspase-8 Inhibitors for Modulating Hematopoiesis

Novel Gene Disruptions, Compositions and Methods Relating Thereto

Methods to identify compounds useful for the treatment of proliferative and differentiative disorders

SGRF gene-modified mouse

Novel Gene Disruptions, Compositions and Methods Relating Thereto

Human cDNA Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their Use

Production of ungulates, preferably bovines that produce human immunoglobulins

TRANSGENIC ANIMALS WITH REDUCED MAJOR URINARY PROTEIN PRODUCTION

Protein formulations comprising s1-5

ABI1 conditional knockout mouse

SPHINGOMYELIN SYNTHASE 2 (SMS2) DEFICIENCY ATTENUATES NFkB ACTIVATION, A POTENTIAL ANTI-ATHEROGENIC PROPERTY

Methods and compositions for RNAi mediated inhibition of gene expression in mammals

Growth differentiation factor-11

Transgenic animals expressing chimeric antibodies for use in preparing human antibodies

Development of a simple animal model for infection by viruses and other obligate intracellular parasites

G-Protein Coupled Receptor and Uses Therefor

Isolated human chromosome 14 fragment encoding immunoglobulin genes

Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)

NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 282P1G3 USEFUL IN TREATMENT AND DETECTION OF CANCER

CISD2-Knockout Mice and Uses Thereof

Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration

METHODS FOR CLONING FERRETS AND TRANSGENIC FERRET MODELS FOR DISEASES

Transgenic non-human animals for pharmacological and toxicological studies

Transgenic porcine models of cystic fibrosis

TREATING HEART FAILURE AND VENTRICULAR ARRHYTHMIAS

Method of identifying compounds using a transgenic pig model of cystic fibrosis

Non-human mammal comprising a modified SERCA2 gene and methods, cells, genes, and vectors thereof

Methods and compositions for using sax2

Modified Dynorphin Expression in Animals and Identification of Compounds for Treatment of Obesity and Diabetes

LYMPHOCYTE SURFACE RECEPTOR THAT BINDS CAML AND METHODS OF USE THEREOF

Method of inhibiting human G-protein chemokine receptor (CCR5) HDGNR10

Method of producing xenogenous antibodies using a bovine

Histone deacetylases, and uses related thereto

Systems and methods for protein production

Lentiviral Vectors That Provide Improved Expression And Reduced Variegation After Transgenesis

ANKTM1, A Cold-Activated TRP-Like Channel Expressed in Nociceptive Neurons

GENES

Gene Involved in V(D)J recombination and/or DNA repair

Caspase-9 deficient animals and the use thereof

Genetically modified non-human mammals and cells

Genomic editing in zebrafish using zinc finger nucleases

Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor

MODEL ANIMAL OF DENDRITIC CELL IMMUNORECEPTOR GENE KNOCKOUT DISEASE

Gene disruptions, compositions and methods relating thereto

Genetically Engineered and Phenotyped Mice and Stem Cell Clones for Producing the Same

Methods for detecting the presence of mutant mammalian presenilin protein

RNA sequence-specific mediators of RNA interference

Truncated Activin Type II Receptor and Methods of Use

Diagnosis of fertility conditions using a serine protease

Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

Mouse carrying a knock-out mutation of the Qpct-gene

Novel apolipoprotein gene involved in lipid metabolism

Transgenic Zebrafish Models for Neurodegenerative Diseases

Identification of a micro-RNA that activates expression of β-myosin heavy chain

Gene for Identifying Individuals with Familial Dysautonomia

Treatment of Conditions Involving Demyelination

Oligodendrocyte-Myelin Glycoprotein Compositions and Methods of Use Thereof

COMPOSITIONS AND METHODS OF MAKING EMBRYONIC STEM CELLS

TREATMENT OF EPILEPSY BY EXPRESSING ST3GAL-III

Expression Vectors Comprising the HS1 Promoter of the VAV1 Oncogene and Use Thereof for the Preparation of Pharmaceutical Compositions Intended for Somatic Gene Therapy

DIRECTED COMPLEMENTATION WITH REMOVABLE GENE OF INTEREST

Noxin, a novel stress-induced gene involved in cell cycle and apoptosis

MOLECULAR SEQUENCE OF SWINE RETROVIRUS AND METHODS OF USE

Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform

Human monoclonal antibodies to influenza M2 protein and methods of making and using same

DNA encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity

TLR ligand and IL-1 Response-Injured Animal Model

Peroxisome proliferator-activator receptor δ (PPARδ) and the development of preimplantation embryos

Characterization of a MEKK binding site and uses thereof

Genotyping methods using genomic sequence of the 5-lipoxygenase-activating protein (FLAP) and polymorphic markers thereof

RNA Interference Mediating Small RNA Molecules

Human antibodies derived from immunized xenomice

Methods of Identifying Modulators of Interaction Between PDZ Domain Proteins and PL Proteins

Indexed library of cells containing genomic modifications and methods of making and utilizing the same

Glycine N-methyltransferase (GNMT) Animal model and use thereof

Beta-secretase enzyme compositions and methods

Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis

Novel Gene Disruptions, Compositions and Methods Relating Thereto

METHODS FOR TREATING A DISORDER BY REGULATING GPRC6A

HBM variants that modulate bone mass and lipid levels

High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds

Mice lacking alpha 1G showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1G T-type calcium channels

Compositions and methods for regulating apoptosis

Epididymal lipocalin gene and uses thereof

Protein and peptide fragments from mouse telomerase reverse transcriptase

Muscle lamin A/C interacting protein, gene encoding same, and uses therefor

Germ cells having inactivated endogenous immunoglobulin genes, and transgenic animals derived therefrom

Mouse in Which Genome is Modified

Method of disrupting heme transport in nematodes and of modelling and evaluating eukaryotic heme transport

Neuromedin u receptor subtype 1 deficient transgenic mice and uses thereof

Sour/Acid Taste Receptors Assays, Genes and Proteins

Targeting constructs for the functional disruption of avian immunoglobulin genes

Model animal causing the white hair development and methods relating thereto

Nucleic acids encoding ChemerinR ligands

Insulin-responsive DNA binding proteins-1 and methods to regulate insulin-responsive genes

CYR61 COMPOSITIONS AND METHODS

Cardiac progenitor cells

Model of Alzheimer's Disease

Methods for Diagnosing and Treating Heart Disease

Genetically Engineered and Photyped Mice and Stem Cell Clones for Producing the Same

GENE SILENCING BY SYSTEMIC RNA INTERFERENCE

MAMMALIAN GRAINYHEAD TRANSCRIPTION FACTORS

PREMATURELY AGEING MOUSE MODELS FOR THE ROLE OF DNA DAMAGE IN AGEING AND INTERVENTION IN AGEING-RELATED PATHOLOGY

Methods for addressing ocular diseases through interference with the wnt signaling pathway

PNMT as a novel marker for progenitor cells

Vldlr-/- mouse models and related methods

Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines

Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited

PRO1190 polypeptides

Chn-1/Chip-Antagonists For The Treatment Of Muscular Diseases

USING CYTOSINE DEAMINASES TO DIMINISH RETROELEMENT TRANSFER FROM PIGS TO HUMANS

PORCINE CMP-N-ACETYLNEURAMINIC ACID HYDROXYLASE GENE

GPR 26 G-Protein Coupled Receptor

Compositions comprising a ligand of Chemerin R

Osteopontin Specific Antibodies and Methods of Use Thereof

AMPK Deficient Animals, Screening Methods, And Related Therapeutics And Diagnostics

CAP/SORBS1 AND DIABETES

Glycine N-methyltransferase (GNMT) animal model and use thereof

METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS & IMPAIRED LUNG FUNCTION & TO ENHANCE LYMPHOCYTE PRODUCTION

TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN ALPHAvBETA6

Method and apparatus for data transmission using multiple transmit antennas

Transgenic animal model of bone mass modulation

AIB1, a novel steroid receptor co-activator

Vascular endothelial growth factor 2

Chromosome 3p21.3 genes are tumor suppressors

Lysyl oxidase-like 1 (LOXL1) and elastogenesis

Oasis gene-deficient mouse

Methods and compounds to alter virus infection

Chicken growth differentiation factor-8

Compositions and methods for altering bone density and bone patterning

Genomic DNA fragments containing regulatory and coding sequences for the B2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments

ANTI-TUMOR VACCINES DELIVERED BY DENDRITIC CELLS DEVOID OF INTERLEUKIN-10

TREATMENT OF CANCER WITH ANTI-MUSCARINIC RECEPTOR AGENTS

TRANSGENIC ORGANISM

Method for modifying chromosomes

Ange gene in atopy

Syndecans and angiogenesis

7B2 Knockout transgenic animals as models of endocrine disease

Es Cell Mutation Method and System

Therapeutic uses of factors which inhibit or neutralize MIF activity

Semaphorin Gene Family

Methods for Detection of Mutations in Myostatin Variants

Novel Gene Disruptions, Compositions and Methods Relating Thereto

Novel Gene Disruptions, Composition and Methods Relating Thereto

BISPECIFIC ANTIBODIES

TRANSGENIC TIEG NON-HUMAN ANIMALS

ECAT16 gene expressed specifically in ES cells and utilization of the same

SELF-INDUCED DELETION OF DNA

Antibody specific for mutant presenilin 2 and method of use thereof

Vascular endothelial growth factor 2

Methods for treating vascular disease